Position in NUVB
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,303,649
-$1,457,724 QoQ
Shares Held
303,881
-1.4% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. NUVB ranks #103 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,303,649 | 303,881 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $2,761,373 | 308,189 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,147,688 | 310,186 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $580,097 | 297,486 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $439,868 | 249,925 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $701,721 | 263,805 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $610,017 | 266,383 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $761,941 | 260,939 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $755,482 | 207,550 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $317,548 | 210,297 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $287,089 | 214,246 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $720,376 | 400,209 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $285,073 | 171,731 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $334,711 | 174,329 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $384,899 | 171,830 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $526,172 | 162,399 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $855,544 | 162,651 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,279,054 | 150,477 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $520,627 | 52,377 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $322,563 | 34,647 | Shares | Sole | 2021-08-05 | |
| No filing history on record for this holder in this stock. | ||||||